zefyr invest a/s
Vores formål Zefyr Invest A/S' investeringer omfatter virksomheder, der som led i en fortsat ekspansion og udvikling har behov for tilførsel af ledelsesmæssige ressourcer og/eller finansiering via egenkapital. Disse investeringer består af veletablerede nichevirksomheder, som drives af et selvstæ…
zefyrinvest.dk ↗Focus
Details
- Type
- Venture Capital
- Headquarters
- Denmark
Similar investors in Denmark
Lovemondays
https://lovemondays.dk/wp-content/uploads/2023/02/IMG_9094-3.mov https://lovemondays.dk/wp-content/uploads/2023/02/IMG_9094-3.mov WE INSPIRE GREAT TEAMS TO SCALE BIG A Venture capital fund backed by lehrmann family We inspire great teams to scale big A VENTURE CAPITAL FUND BACKED BY LEHRMANN FAMILY Looking for Nordic seed stage SaaS, Marketplaces and Consumer businesses. Initial ticket size 1-3m EUR potential big follow up. Become one of the few
Bumble Ventures
In a post-AI world of infinite supply, human attention is the ultimate scarce resource . We invest in the proprietary audiences, communities, and IP that hold, compound, and monetize that scarcity. As hyper commoditization strips software and content of pricing power, controlling the last mile - the direct, un-intermediated relationship with the consumer - has become the single most critical choke point for enterprise value.
vxc holding aps
Vi kigger udelukkende efter ild i øjnene på de folk vi arbejder med VXC er en forretnings-/konceptudviklingsvirksomhed med speciale i teknologiske projekter. Vi har hovedsæde i København og har eksisteret på det danske marked siden 2010. VXC er i dag et privatejet selskab, med partnere i stærke ledelsesteams investerer i udvikling af virksomheder
Seed Capital
We back exceptional Nordic-based founders all the way to exit. More than 70% of our companies convert from seed to Series A, making us one of the best-performing funds in Europe. We’ve made 60 investments, 10 exits and 5 IPOs over the past two decades and have just raised €140M for our next fund.
nb capital aps
Representative Investments by Florian Schönharting Role: Co-Founder Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and autoimmune diseases, based on proprietary next generation antibody technologies. Ticker: GEN.CO - Market cap:
Black Capital Ventures
We invest in a better world. We are a small green venture capital fund with a large feel. We are dedicated to making the world we live in a better place. Our investment focus is on high-tech startups in the GreenTech and MedTech space. Reach out to hear more about us